252 related articles for article (PubMed ID: 11173546)
1. Anti-angiogenic treatment for peritoneal dissemination of pancreas adenocarcinoma: a study using TNP-470.
Kato H; Ishikura H; Kawarada Y; Furuya M; Kondo S; Kato H; Yoshiki T
Jpn J Cancer Res; 2001 Jan; 92(1):67-73. PubMed ID: 11173546
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth.
Hotz HG; Reber HA; Hotz B; Sanghavi PC; Yu T; Foitzik T; Buhr HJ; Hines OJ
J Gastrointest Surg; 2001; 5(2):131-8. PubMed ID: 11331474
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo.
Kawarada Y; Ishikura H; Kishimoto T; Saito K; Takahashi T; Kato H; Yoshiki T
Pancreas; 1997 Oct; 15(3):251-7. PubMed ID: 9336788
[TBL] [Abstract][Full Text] [Related]
4. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin.
Shishido T; Yasoshima T; Denno R; Mukaiya M; Sato N; Hirata K
Jpn J Cancer Res; 1998 Sep; 89(9):963-9. PubMed ID: 9818033
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic potential of prostate carcinoma cells overexpressing bcl-2.
Fernandez A; Udagawa T; Schwesinger C; Beecken W; Achilles-Gerte E; McDonnell T; D'Amato R
J Natl Cancer Inst; 2001 Feb; 93(3):208-13. PubMed ID: 11158189
[TBL] [Abstract][Full Text] [Related]
7. [Implication of vascular endothelial growth factor (VEGF) in human head and neck cancer].
Ueno Y
Nihon Jibiinkoka Gakkai Kaiho; 2006 Mar; 109(3):163-70. PubMed ID: 16615431
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiogenesis inhibitor TNP-470 on the progression of human gastric cancer xenotransplanted into nude mice.
Kanai T; Konno H; Tanaka T; Matsumoto K; Baba M; Nakamura S; Baba S
Int J Cancer; 1997 May; 71(5):838-41. PubMed ID: 9180154
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis inhibitor TNP-470 suppresses growth of peritoneal disseminating foci of human colon cancer line Lovo.
Fan YF; Huang ZH
World J Gastroenterol; 2002 Oct; 8(5):853-6. PubMed ID: 12378629
[TBL] [Abstract][Full Text] [Related]
10. Contribution of angiogenesis to the progression of colon cancer: possible inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and hepatic metastasis.
Takatsuka S; Yamada N; Sawada T; Ogawa Y; Maeda K; Ohira M; Ishikawa T; Nishino H; Seki S; Hirakawa-YS Chung K
Int J Oncol; 2000 Aug; 17(2):253-8. PubMed ID: 10891532
[TBL] [Abstract][Full Text] [Related]
11. Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction.
Saijo Y; Tanaka M; Miki M; Usui K; Suzuki T; Maemondo M; Hong X; Tazawa R; Kikuchi T; Matsushima K; Nukiwa T
J Immunol; 2002 Jul; 169(1):469-75. PubMed ID: 12077278
[TBL] [Abstract][Full Text] [Related]
12. Suppression of tumor growth and downregulation of platelet-derived endothelial cell growth factor / thymidine phosphorylase in tumor cells by angiogenesis inhibitor TNP-470.
Mori J; Haisa M; Naomoto Y; Takaoka M; Kimura M; Yamatsuji T; Notohara K; Tanaka N
Jpn J Cancer Res; 2000 Jun; 91(6):643-50. PubMed ID: 10874218
[TBL] [Abstract][Full Text] [Related]
13. Induction of vascular endothelial growth factor (VEGF) by hyperthermia and/or an angiogenesis inhibitor.
Kanamori S; Nishimura Y; Okuno Y; Horii N; Saga T; Hiraoka M
Int J Hyperthermia; 1999; 15(4):267-78. PubMed ID: 10458567
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.
Gervaz P; Scholl B; Padrun V; Gillet M
Liver; 2000 Apr; 20(2):108-13. PubMed ID: 10847478
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effects of TNP-470 in combination with 5-fluorouracil on growth of human colon cancer].
Fan YF; Huang ZH; Nie J
Ai Zheng; 2002 Dec; 21(12):1319-23. PubMed ID: 12520739
[TBL] [Abstract][Full Text] [Related]
16. [The effect of TNP-470 on the proliferation and apoptosis of lung adenocarcinoma cells].
Ma X; Zhang L; Kang J; Yu R
Zhonghua Nei Ke Za Zhi; 2002 Apr; 41(4):244-7. PubMed ID: 12133436
[TBL] [Abstract][Full Text] [Related]
17. The effect of the anti-angiogenic agent TNP-470 on tumor growth and vascularity in low passaged xenografts of human gliomas in nude mice.
Bernsen HJ; Rijken PF; Peters H; Bakker H; van der Kogel AJ
J Neurooncol; 1998 May; 38(1):51-7. PubMed ID: 9540057
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis inhibitor, TNP-470, suppresses growth of peritoneal disseminating foci.
Yoshikawa T; Yanoma S; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
Hepatogastroenterology; 2000; 47(31):298-302. PubMed ID: 10690624
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts.
Lund EL; Bastholm L; Kristjansen PE
Clin Cancer Res; 2000 Mar; 6(3):971-8. PubMed ID: 10741723
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel enhances the therapeutic effect of the angiogenesis inhibitor TNP-470 (AGM-1470) in metastatic human transitional cell carcinoma.
Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
Clin Cancer Res; 2003 Feb; 9(2):886-99. PubMed ID: 12576464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
